Filana Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Filana Therapeutics, Inc. (FLNA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $113.36 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-12
- Filana Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-03-31 was $113.36M.
- Filana Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $113.36M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2024-12-31 | $113.36M 10-K · filed 2026-03-12 | |
| 2024-03-31 | $113.36M 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |